• Overview
    • Investor Relations
      • Overview
      • Why Invest
        • Our Story
        • Prospective Investors
        • Sustainability Bond
        • ESG Report
        • Fact Sheet
        • Investor Email Alerts
      • Events & Presentations
      • Financials
        • Quarterly Results
        • Annual Reports
        • SEC Filings
        • Viatris Transaction
      • News
      • Stock Info
        • Stock Quote
        • Stock Chart
        • Historical Stock Quote
        • Investment Calculator
        • Dividend & Split History
        • Stock FAQs
      • Corporate Governance
        • Corporate Governance Overview
        • Board of Directors
        • Board Committees & Charters
        • Corporate Governance Documents
        • Board Policies
        • Corporate Governance FAQs
        • Contact Our Directors
        • More Resources
      • Shareholder Services
        • Shareholder Services Overview
        • Pfizer Investor Insights
        • Stock FAQs
        • Cost Basis Calculator
        • Supplemental Annual Meeting Q&A
    • Science
      • Clinical Trials
        • Guide to Clinical Trials

          Your participation makes a difference
        • Clinical Trials in Children

          Designed to improve kids' health
        • Data and Results

          Sharing our Results
        • Integrity and Transparency

          Building Trust
        • Diversity

          Equity and Representation
        • Plain Language Study Results

          Trial Result Summaries
        • Expanded Access & Compassionate Use

          Possible Treatment Options
      • Find a Trial
      • Areas of Focus
        • Rare Disease

          Smaller populations but big impact
        • Internal Medicine

          Extending lifespans worldwide
        • Inflammation & Immunology

          Treatment at the molecular level
        • Vaccines

          Preventing the spread of infections
        • Oncology

          The science of optimism
        • Anti Infectives

          Combatting an evolving risk
      • Areas of Innovation
        • Gene Therapy

          Breakthroughs become treatments
        • Medicinal Sciences

          The next generation of science
        • Precision Medicine

          Developing tailored medicines
        • Maternal Immunization

          Protecting newborns at the start
        • mRNA Technology

          Unleashing the next wave of scientific innovations
      • Diseases & Conditions
      • Coronavirus Resources
      • Product Pipeline
      • Research Sites
    • Products
      • How Drugs Are Made
        • Branded vs. Generic

          Learn the difference
        • Biologics & Biosimilars

          Cures found in nature
        • Commitment to Quality

          Maintaining the highest standards
        • Global Supply

          Strategic manufacturing locations
        • Manufacturing Sites

          Where medicine is made in the U.S.
      • Medicine Safety
        • Health Literacy

          Learning to be well
        • Treatment Choices

          Learning about treatment decisions
        • Partnering with Patients

          Helping others by reporting side effects
        • Tips for Patients

          Preventing medication errors
        • Reporting Adverse Events
        • Counterfeiting

          Preventing medication errors
        • Safety Data Sheets
      • Product List
      • Product Contacts
      • PfizerPro for Professionals
      • Patient Assistance Programs
      • Distributors
        • Pfizer Distributors
        • Greenstone Distributors
    • Stories
      • Articles
      • Announcements
      • Behind the Science Features
        • Online Counterfeit Medicines

          Combating the Rise
        • When AI Meets Biology

          A Special Partnership
        • What is mRNA?

          mRNA Defined and Applied
        • COVID-19 Vaccine Rollout

          New Digital Technologies
        • COVID-19 Vaccine

          Distributing Hope to the World
        • Clinical Trials

          Where Science Meets Patients
        • Medicinal Sciences

          The Art of Creating New Medicines
      • Podcasts
      • eBooks
    • Newsroom
      • Press Releases
      • Media Asset Library
      • Update & Statements
      • Partnering News
      • Media Contacts
    • About
      • People
        • Executives

          Our senior-most leadership
        • Board Members

          The people steering our company
        • Scientists

          Our experts making discoveries
        • Patient Stories

          Our patients
      • Responsibility
        • Compliance

          Each of us is responsible
        • Diversity, Equity and Inclusion

          Everyone has something to offer
        • Corporate Compliance
        • EHS Governance
        • Environmental Sustainability

          Our responsibility to the environment
        • Global Impact

          Meeting urgent needs worldwide
        • Health Safety
        • Human Rights

          Furthering dignity and worth
        • Intellectual Property

          The benefits of fair competition
        • Patient Advocacy & Engagement

          Putting Patients First
      • Programs & Policies
        • Grants

          Support for independent research
        • Political Partnership

          Supporting like-minded organizations
        • Working with Healthcare Professionals

          Collaboration to improve lives
        • Prescription Value & Pricing

          How to lower patient costs
        • Ready for Cures

          Improving Access to Medicines
        • Transparency in Grants

          Committed to Disclosure
      • Investors
        • Investors Overview

          Information for stockholders
        • Why Invest

          Why to join us on our mission
        • Events & Presentations

          Calendar of upcoming events
        • Financial Reports

          Quarterly reports and more
        • Investor News

          Announcements about our performance
        • Stock Information

          Charts and data
        • Shareholder Services

          Information on stock transactions
      • Corporate Governance
        • Corporate Governance Overview

          Gaining insight into our performance
        • Board Committees & Charters

          Defining the corporate structure
        • The Pfizer Board Policies

          Ensuring ethical leadership
        • Corporate Governance FAQs

          Learn more about our approach
        • Contact Our Directors

          Email any of our Directors
      • History
      • Careers
        • Search Jobs
        • Connect With Us
      • Partners
        • Research and Business Development Partnerships
        • Venture Investments
        • Business to Business
        • Pfizer CentreOne
        • Submit Your Opportunities
Skip to main content
Pfizer Inc.
Current Location and Language
United States
 - English
Argentina
 - Español
Australia
 - English
Austria
 - Deutsch
Belarus
 - Belarusian - English
Belgium
 - English - Nederlands - Français
Brazil
 - Português
Bulgaria
 - Български
Canada
 - English - Français
China
 - 中文 - English
Chile
 - Español
Colombia
 - Español
Croatia
 - Croatian
Czech Republic
 - Čeština
Denmark
 - Dansk
Ecuador
 - Español
Estonia
 - Eesti - English
Finland
 - Suomalainen
France
 - Français
Germany
 - Deutsch
Greece
 - ελληνικά
Hong Kong
 - 繁體中文 - English
Hungary
 - Magyar
India
 - English
Indonesia
 - Indonesian
Ireland
 - English
Israel
 - עברית
Italy
 - Italiano
Japan
 - 日本の
Korea
 - 한국의
Latvia
 - Latvian - English
Lithuania
 - Lithuanian - English
Malaysia
 - English
Mexico
 - Español
Netherlands
 - Nederlands
New Zealand
 - English
Norway
 - Norsk
Pakistan
 - English
Peru
 - Español
Philippines
 - English
Poland
 - Polski
Portugal
 - Português
Russia
 - Русский
Romania
 - Română
Serbia
 - Serbian
Saudi Arabia
 - English - العربية
Singapore
 - English
Slovenia
 - Slovenian
Slovakia
 - Slovenský
South Africa
 - English
Spain
 - Español
Sweden
 - Svenska
Switzerland
 - Deutsch - Français
Taiwan
 - Taiwan
Thailand
 - ภาษาไทย
Tunisia
 - Français
Turkey
 - Türk
United Kingdom
 - English
United States
 - English
Ukraine
 - Ukrainian
Vietnam
 - Tiếng Việt - English
Venezuela
 - Español
  • Overview
    • Investor Relations
      • Overview
      • Why Invest
        • Our Story
        • Prospective Investors
        • Sustainability Bond
        • ESG Report
        • Fact Sheet
        • Investor Email Alerts
      • Events & Presentations
      • Financials
        • Quarterly Results
        • Annual Reports
        • SEC Filings
        • Viatris Transaction
      • News
      • Stock Info
        • Stock Quote
        • Stock Chart
        • Historical Stock Quote
        • Investment Calculator
        • Dividend & Split History
        • Stock FAQs
      • Corporate Governance
        • Corporate Governance Overview
        • Board of Directors
        • Board Committees & Charters
        • Corporate Governance Documents
        • Board Policies
        • Corporate Governance FAQs
        • Contact Our Directors
        • More Resources
      • Shareholder Services
        • Shareholder Services Overview
        • Pfizer Investor Insights
        • Stock FAQs
        • Cost Basis Calculator
        • Supplemental Annual Meeting Q&A
    • Science
      • Clinical Trials
        • Guide to Clinical Trials

          Your participation makes a difference
        • Clinical Trials in Children

          Designed to improve kids' health
        • Data and Results

          Sharing our Results
        • Integrity and Transparency

          Building Trust
        • Diversity

          Equity and Representation
        • Plain Language Study Results

          Trial Result Summaries
        • Expanded Access & Compassionate Use

          Possible Treatment Options
      • Find a Trial
      • Areas of Focus
        • Rare Disease

          Smaller populations but big impact
        • Internal Medicine

          Extending lifespans worldwide
        • Inflammation & Immunology

          Treatment at the molecular level
        • Vaccines

          Preventing the spread of infections
        • Oncology

          The science of optimism
        • Anti Infectives

          Combatting an evolving risk
      • Areas of Innovation
        • Gene Therapy

          Breakthroughs become treatments
        • Medicinal Sciences

          The next generation of science
        • Precision Medicine

          Developing tailored medicines
        • Maternal Immunization

          Protecting newborns at the start
        • mRNA Technology

          Unleashing the next wave of scientific innovations
      • Diseases & Conditions
      • Coronavirus Resources
      • Product Pipeline
      • Research Sites
    • Products
      • How Drugs Are Made
        • Branded vs. Generic

          Learn the difference
        • Biologics & Biosimilars

          Cures found in nature
        • Commitment to Quality

          Maintaining the highest standards
        • Global Supply

          Strategic manufacturing locations
        • Manufacturing Sites

          Where medicine is made in the U.S.
      • Medicine Safety
        • Health Literacy

          Learning to be well
        • Treatment Choices

          Learning about treatment decisions
        • Partnering with Patients

          Helping others by reporting side effects
        • Tips for Patients

          Preventing medication errors
        • Reporting Adverse Events
        • Counterfeiting

          Preventing medication errors
        • Safety Data Sheets
      • Product List
      • Product Contacts
      • PfizerPro for Professionals
      • Patient Assistance Programs
      • Distributors
        • Pfizer Distributors
        • Greenstone Distributors
    • Stories
      • Articles
      • Announcements
      • Behind the Science Features
        • Online Counterfeit Medicines

          Combating the Rise
        • When AI Meets Biology

          A Special Partnership
        • What is mRNA?

          mRNA Defined and Applied
        • COVID-19 Vaccine Rollout

          New Digital Technologies
        • COVID-19 Vaccine

          Distributing Hope to the World
        • Clinical Trials

          Where Science Meets Patients
        • Medicinal Sciences

          The Art of Creating New Medicines
      • Podcasts
      • eBooks
    • Newsroom
      • Press Releases
      • Media Asset Library
      • Update & Statements
      • Partnering News
      • Media Contacts
    • About
      • People
        • Executives

          Our senior-most leadership
        • Board Members

          The people steering our company
        • Scientists

          Our experts making discoveries
        • Patient Stories

          Our patients
      • Responsibility
        • Compliance

          Each of us is responsible
        • Diversity, Equity and Inclusion

          Everyone has something to offer
        • Corporate Compliance
        • EHS Governance
        • Environmental Sustainability

          Our responsibility to the environment
        • Global Impact

          Meeting urgent needs worldwide
        • Health Safety
        • Human Rights

          Furthering dignity and worth
        • Intellectual Property

          The benefits of fair competition
        • Patient Advocacy & Engagement

          Putting Patients First
      • Programs & Policies
        • Grants

          Support for independent research
        • Political Partnership

          Supporting like-minded organizations
        • Working with Healthcare Professionals

          Collaboration to improve lives
        • Prescription Value & Pricing

          How to lower patient costs
        • Ready for Cures

          Improving Access to Medicines
        • Transparency in Grants

          Committed to Disclosure
      • Investors
        • Investors Overview

          Information for stockholders
        • Why Invest

          Why to join us on our mission
        • Events & Presentations

          Calendar of upcoming events
        • Financial Reports

          Quarterly reports and more
        • Investor News

          Announcements about our performance
        • Stock Information

          Charts and data
        • Shareholder Services

          Information on stock transactions
      • Corporate Governance
        • Corporate Governance Overview

          Gaining insight into our performance
        • Board Committees & Charters

          Defining the corporate structure
        • The Pfizer Board Policies

          Ensuring ethical leadership
        • Corporate Governance FAQs

          Learn more about our approach
        • Contact Our Directors

          Email any of our Directors
      • History
      • Careers
        • Search Jobs
        • Connect With Us
      • Partners
        • Research and Business Development Partnerships
        • Venture Investments
        • Business to Business
        • Pfizer CentreOne
        • Submit Your Opportunities
Overview

Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Pfizer, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Pfizer to send you the requested Investor Email Alert updates.

* Required

*
Investor Alert Options
*





Email Alert Sign Up Confirmation

Pfizer Inc. Logo
  • Investors
  • Careers
  • Media
  • Partners
  • Grant Seekers
  • Health Care Professionals
  • Business To Business
  • Merchandise
  • Privacy Statement
  • Terms Of Use
  • Contact Us
United States © Pfizer Inc. All rights reserved
  • Twitter link
  • Facebook link
  • Linkedin link
  • Instagram link
  • YouTube link

Forward-Looking Statements of Pfizer Inc.

This transcript may contain forward-looking statements about, among other things, our anticipated operating and financial performance, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, post-approval clinical trial results and other developing data that become available, revenue contribution, growth, performance, timing of exclusivity and potential benefits; manufacturing and product supply; our efforts to respond to COVID-19, including our development of a vaccine to help prevent COVID-19 and our investigational protease inhibitor; our expectations regarding the impact of COVID-19 on our business; plans for and prospects of our acquisitions, dispositions and other business-development activities, and our ability to successfully capitalize on these opportunities; and discussions relating to strategic reviews, capital allocation objectives, dividends and share repurchases, among other things, that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.

A description of these risks and uncertainties can be found in Pfizer’s most recent Annual Report on Form 10-K and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.

The forward-looking statements in the transcript speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

I Accept

Forward-Looking Statements of Pfizer Inc.

This webcast may contain forward-looking statements about, among other things, our anticipated operating and financial performance, reorganizations, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, clinical trial results and other developing data that become available, revenue contribution, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities, and our ability to successfully capitalize on these opportunities; manufacturing and product supply; our efforts to respond to COVID-19, including the Pfizer-BioNTech COVID-19 vaccine and our investigational protease inhibitor; and our expectations regarding the impact of COVID-19 on our business that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.

A description of these risks and uncertainties can be found in Pfizer’s most recent Annual Report on Form 10-K and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.

The forward-looking statements in the transcript speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

I Accept